New therapeutic agents in thrombosis and thrombolysis / edited by Jane E. Freedman, Joseph Loscalzo
As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Edition is a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for treating cardiovascular and thromboembolic diseases.New to the Third Edition:a thorough examination of all the agents involved in treating thrombosischapters on biomarkers, testing, and pharmacogenomicskey topics, including new targets for antithrombotic.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
c2009 |
|---|---|
| Erschienen: |
New York: Informa Healthcare ; c2009 |
| Ausgabe: |
3rd ed |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Freedman, Jane E. [Sonstige Person] |
|---|
| Links: |
|---|
| ISBN: |
|---|
| Nlm: |
QZ 170 W1 |
|---|---|
| Themen: |
Fibrinolytic Agents |
| Anmerkungen: |
Includes bibliographical references and index |
|---|
| Umfang: |
Online-Ressource (xv, 690 p) ; IllustratorIn |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
808631020 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 808631020 | ||
| 003 | DE-627 | ||
| 005 | 20221010140133.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 141203s2009 xxu|||||o 00| ||eng c | ||
| 020 | |a 1282278282 |c ebk |9 1-282-27828-2 | ||
| 020 | |a 9781282278288 |c MyiLibrary |9 978-1-282-27828-8 | ||
| 020 | |a 9781420069242 |c electronic |9 978-1-4200-6924-2 | ||
| 035 | |a (DE-627)808631020 | ||
| 035 | |a (DE-599)GBV808631020 | ||
| 035 | |a (RPAM)cis23765919 | ||
| 035 | |a (EBC)EBC1406690 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 050 | 0 | |a RC694.3 | |
| 060 | 0 | |a QZ 170 | |
| 060 | 0 | |a W1 | |
| 082 | 0 | |a 616.1/3506 |2 22 | |
| 245 | 1 | 0 | |a New therapeutic agents in thrombosis and thrombolysis |c edited by Jane E. Freedman, Joseph Loscalzo |
| 250 | |a 3rd ed | ||
| 264 | 1 | |a New York |b Informa Healthcare |c c2009 | |
| 300 | |a Online-Ressource (xv, 690 p) |b ill | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Fundamental and clinical cardiology |v 65 | |
| 500 | |a Includes bibliographical references and index | ||
| 505 | 8 | 0 | |a Front Cover; Title Page; Series Introduction; Preface; Table of Contents; Contributors; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Chapter 19; Chapter 20; Chapter 21; Chapter 22; Chapter 23; Chapter 24; Chapter 25; Chapter 26; Chapter 27; Chapter 28; Chapter 29; Chapter 30; Chapter 31; Chapter 32; Chapter 33; Chapter 34; Chapter 35; Chapter 36; Chapter 37; Chapter 38; Index; Back Cover |
| 520 | |a As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Edition is a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for treating cardiovascular and thromboembolic diseases.New to the Third Edition:a thorough examination of all the agents involved in treating thrombosischapters on biomarkers, testing, and pharmacogenomicskey topics, including new targets for antithrombotic | ||
| 650 | 0 | |a Fibrinolytic agents | |
| 650 | 0 | |a Thrombosis | |
| 650 | 0 | |a Thrombolytic therapy | |
| 650 | 2 | |a Fibrinolytic Agents |x therapeutic use | |
| 650 | 2 | |a Hemostasis |x drug effects | |
| 650 | 2 | |a Platelet Aggregation Inhibitors |x therapeutic use | |
| 650 | 2 | |a Thrombosis |x drug therapy | |
| 650 | 2 | |a Thrombolytic Therapy | |
| 700 | 1 | |a Freedman, Jane E. |4 oth | |
| 700 | 1 | |a Loscalzo, Joseph |4 oth | |
| 776 | 1 | |z 1282277456 | |
| 776 | 1 | |z 9781420069235 | |
| 776 | 0 | 8 | |i Print version |a New Therapeutic Agents in Thrombosis and Thrombolysis, Third Edition |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=1406690 |x Aggregator |3 Volltext |
| 856 | 4 | 2 | |u http://www.gbv.de/dms/bowker/toc/9781420069235.pdf |m V:DE-601 |m X:Bowker |q pdf/application |v 2015-03-18 |x Verlag |y Inhaltsverzeichnis |3 Inhaltsverzeichnis |
| 912 | |a ZDB-26-MYL | ||
| 912 | |a ZDB-30-PQE | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a ISIL_DE-Brg3 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.1/3506 | ||
| 980 | |2 206 |1 01 |x 3350 |b 1556819404 |c 00 |f --%%-- |d Online-Ressource |e g |j --%%-- |h OLR-EBL |k If you are a ThHF affiliate and the E-Book is not fully accessible, please send us a purchase or short time loan request. All others: Inter-library loans and guest access on campus premises is not possible. |y zh |z 24-07-15 | ||
| 981 | |2 206 |1 01 |x 3350 |y Full Text only for ThHF affiliates |r https://thh-friedensau.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=1406690 | ||
| 995 | |2 206 |1 01 |x 3350 |a OLR-EBL | ||